Duchenne's Muscular Dystrophy (DMD) Terminated Phase 1 / 2 Trials for Halofuginone (DB04866)

Also known as: Duchenne's Muscular Dystrophy / Duchenne Muscular Dystrophy (DMD) / Duchenne Muscular Dystrophy / Muscular Dystrophy, Duchenne / Muscular dystrophy

IndicationStatusPhase
DBCOND0066749 (Duchenne's Muscular Dystrophy (DMD))Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01847573Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular DystrophyTreatment